TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q4 2014. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $22,000 | -38.9% | 2,000 | 0.0% | 0.02% | -34.4% |
Q2 2015 | $36,000 | -7.7% | 2,000 | 0.0% | 0.03% | -5.9% |
Q1 2015 | $39,000 | +11.4% | 2,000 | 0.0% | 0.03% | +13.3% |
Q4 2014 | $35,000 | -99.9% | 2,000 | 0.0% | 0.03% | -11.8% |
Q3 2014 | $36,540,000 | -20.7% | 2,000 | 0.0% | 0.03% | -19.0% |
Q2 2014 | $46,060,000 | – | 2,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |